Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?

The discordance between pre-clinical success and clinical failure of treatment options for Duchenne Muscular Dystrophy (DMD) is significant. The termination of clinical trials investigating the phosphodiesterase inhibitors, sildenafil and tadalafil (which prolong the second messenger molecule of nit...

Descripción completa

Detalles Bibliográficos
Autores principales: Timpani, Cara A., Mamchaoui, Kamel, Butler-Browne, Gillian, Rybalka, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764682/
https://www.ncbi.nlm.nih.gov/pubmed/33322149
http://dx.doi.org/10.3390/antiox9121268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764682/
https://www.ncbi.nlm.nih.gov/pubmed/33322149
http://dx.doi.org/10.3390/antiox9121268

Ejemplares similares